Why did ORPH.IR stock spike in pre-market trading?

The pre-market spike came from **15,112** shares traded versus an average **192**, creating extreme relative volume. ORPH.IR stock often reacts to trial news, contract awards, or dataset licensing interest; with thin liquidity, order concentration can drive rapid moves.

What are the key technical levels to watch for ORPH.IR stock?

Watch immediate support at **EUR 0.14**, 50-day average **EUR 0.1391**, and resistance near the 200-day average **EUR 0.17113**. Year high **EUR 0.28** and year low **EUR 0.13** are useful risk anchors for traders.

What is Meyka AI's price outlook for ORPH.IR stock?

Meyka AI's forecast model projects a base target of **EUR 0.20** (+**42.86%**), a bear **EUR 0.10** (-**28.57%**), and a bull **EUR 0.28** (+**100.00%**) from the current **EUR 0.14**. Forecasts are model-based projections and not guarantees.

How does ORPH.IR stock compare to the Healthcare sector?

ORPH.IR stock shows a trailing PE of **7.79**, below the Healthcare sector average PE **34.64**. That suggests a cheaper trailing valuation, but sector dynamics and company-specific catalysts remain decisive for performance.

EU Stocks

ORPH.IR Open Orphan Plc EURONEXT pre-market 22 Jan 2026: Volume surges to 15,112, monitor EUR 0.14 support

ByDanny Kontos January 22, 2026

Pre-market trading shows an early volume spike in ORPH.IR stock, with 15,112 shares traded at EUR 0.14 as of 22 Jan 2026. The current print equals the previous close and sits just above the 50-day average EUR 0.1391, while average daily volume is 192. We flag the jump because relative volume is 78.71, a large increase that can magnify short-term moves. For Europe-listed healthcare names, a spike of this size signals active order flow and warrants watching immediate support at EUR 0.14 and resistance near the 50-day and 200-day averages.